Page last updated: 2024-08-24

relcovaptan and Hypertension

relcovaptan has been researched along with Hypertension in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Streefkerk, JO; van Zwieten, PA	1
Brouard, R; DiBlasi, TP; Kilani, A; Leenhardt, AF; Rahman, M; Smith, MC; Thibonnier, M; Warner, K	1
Barthelmebs, M; Cazaubon, C; De Jong, W; Grima, M; Imbs, JL; Loichot, C; Nisato, D	1
Dapzol, J; Girod, V; Grélot, L; Maffrand, JP; Serradeil-Le Gal, C	1

Reviews

1 review(s) available for relcovaptan and Hypertension

Article	Year
Vasopressin receptor antagonists: pharmacological tools and potential therapeutic agents. Autonomic & autacoid pharmacology, 2006, Volume: 26, Issue:2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Drug Design; Heart Failure; Hormone Antagonists; Humans; Hypertension; Inappropriate ADH Syndrome; Indoles; Presynaptic Terminals; Pyrrolidines; Receptors, Vasopressin; Renal Artery; Sympathetic Nervous System; Synaptic Transmission; Tolvaptan; Vasoconstriction; Vasoconstrictor Agents	2006

Article

Year

Vasopressin receptor antagonists: pharmacological tools and potential therapeutic agents.

Autonomic & autacoid pharmacology, 2006, Volume: 26, Issue:2

Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Drug Design; Heart Failure; Hormone Antagonists; Humans; Hypertension; Inappropriate ADH Syndrome; Indoles; Presynaptic Terminals; Pyrrolidines; Receptors, Vasopressin; Renal Artery; Sympathetic Nervous System; Synaptic Transmission; Tolvaptan; Vasoconstriction; Vasoconstrictor Agents

2006

Trials

1 trial(s) available for relcovaptan and Hypertension

Article	Year
Effects of the nonpeptide V(1) vasopressin receptor antagonist SR49059 in hypertensive patients. Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:6 Topics: Administration, Oral; Adult; Aldosterone; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Black People; Blood Volume; Cross-Over Studies; Double-Blind Method; Heart Rate; Hormone Antagonists; Humans; Hypertension; Indoles; Kidney Function Tests; Male; Platelet Aggregation; Pyrrolidines; Renin; Serum Albumin; Sodium; Treatment Outcome; White People	1999

Article

Year

Effects of the nonpeptide V(1) vasopressin receptor antagonist SR49059 in hypertensive patients.

Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:6

Topics: Administration, Oral; Adult; Aldosterone; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Black People; Blood Volume; Cross-Over Studies; Double-Blind Method; Heart Rate; Hormone Antagonists; Humans; Hypertension; Indoles; Kidney Function Tests; Male; Platelet Aggregation; Pyrrolidines; Renin; Serum Albumin; Sodium; Treatment Outcome; White People

1999

Other Studies

2 other study(ies) available for relcovaptan and Hypertension

Article	Year
Vasopressin does not effect hypertension caused by long-term nitric oxide inhibition. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:2 Topics: Albuminuria; Animals; Antidiuretic Hormone Receptor Antagonists; Blood Pressure; Enzyme Inhibitors; Heart; Heart Rate; Hypertension; Indoles; Kidney; Male; Nitric Acid; Nitric Oxide Synthase; Nitroarginine; Organ Size; Pyrrolidines; Rats; Rats, Sprague-Dawley; Systole; Time Factors; Vasopressins	2000
A nonpeptide vasopressin V(1a) receptor antagonist, SR 49059, does not prevent cisplatin-induced emesis in piglets. Fundamental & clinical pharmacology, 2001, Volume: 15, Issue:3 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Antiemetics; Antineoplastic Agents; Arginine Vasopressin; Cell Membrane; Cisplatin; Disease Models, Animal; Hormone Antagonists; Hypertension; Indoles; Liver; Pyrrolidines; Swine; Vomiting	2001

Article

Year

Vasopressin does not effect hypertension caused by long-term nitric oxide inhibition.

Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:2

Topics: Albuminuria; Animals; Antidiuretic Hormone Receptor Antagonists; Blood Pressure; Enzyme Inhibitors; Heart; Heart Rate; Hypertension; Indoles; Kidney; Male; Nitric Acid; Nitric Oxide Synthase; Nitroarginine; Organ Size; Pyrrolidines; Rats; Rats, Sprague-Dawley; Systole; Time Factors; Vasopressins

2000

A nonpeptide vasopressin V(1a) receptor antagonist, SR 49059, does not prevent cisplatin-induced emesis in piglets.

Fundamental & clinical pharmacology, 2001, Volume: 15, Issue:3

Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Antiemetics; Antineoplastic Agents; Arginine Vasopressin; Cell Membrane; Cisplatin; Disease Models, Animal; Hormone Antagonists; Hypertension; Indoles; Liver; Pyrrolidines; Swine; Vomiting

2001